SCHEMBL6735447

SCHEMBL6735447

CCCCCc1cc2cc3ccc(CCC)cc3cc2c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 9/20 0.40
BDKRB2 P30411 1/20 0.36
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX5 P09917 1/20 0.34
MAPT P10636 1/20 0.34
TYR P14679 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HTR1A P08908 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
GPR3 P46089 1/20 0.33
S1PR1 P21453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6734816 0.96 TLR8 (0.43) TLR8BDKRB2TP53CYP3A4HTR1A
SCHEMBL6731332 0.96 TLR8 (0.35) TLR8BDKRB2CNR1CNR2ALOX5
SCHEMBL6732184 0.95 TLR8 (0.42) TLR8BDKRB2TP53CYP3A4HTR1A
SCHEMBL6731904 0.95 TLR8 (0.40) TLR8BDKRB2TP53CYP3A4HTR1A
SCHEMBL6731773 0.95 TLR8 (0.42) TLR8BDKRB2TP53CYP3A4HTR1A
SCHEMBL6732169 0.92 CYP1A2 (0.39) TLR8BDKRB2MEN1TP53CYP3A4
SCHEMBL6736893 0.92 TLR8 (0.39) TLR8BDKRB2TYRHTR1A
SCHEMBL6741609 0.90 SKP2 (0.36) TLR8BDKRB2ALOX5HTR1A
SCHEMBL6731242 0.89 TLR8 (0.40) TLR8BDKRB2HTR1AHTR1DHTR1B
SCHEMBL6736312 0.88 CYP1A2 (0.40) TLR8BDKRB2TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6682785-B2 A FLUOROANTHRACENE COMPOUNDS; HEAT RESISTANCE, RADIATION RESISTANCE, PHOTOSTABILITY CLARIANT FINANCE (BVI) LIMITED (VG) 2004-01-27 US disclosed
US-20030118749-A1 A fluoroanthracene compounds; heat resistance, radiation resistance, photostability CLARIANT INTERNATIONAL LTD. 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030118749-A1 A fluoroanthracene compounds; heat resistance, radiation resistance, photostability HSF1, ABCC1, FLNA TLR8 3408/4885BDKRB2 3182/4885CNR1 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.